TLACPH Consulting ApS: Financial statements 2024
CVR: 40250360
Source: annual report 2024, Danish Business Authority
01/04/2023 – 31/03/2024
TLACPH Consulting ApS (CVR 40250360) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 78,336 and a net result of DKK 53,389 compared with DKK 226,237 the year before. The profit margin was 68.2%. Equity in the 2024 report amounted to DKK 167,492. The solvency ratio was 67.8%.
- Revenue
- DKK 78,336
- Gross Profit
- DKK 63,480
- Profit/Loss
- DKK 53,389
- Equity
- DKK 167,492
- Total Assets
- DKK 247,011
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 78 t. | 63 t. | 53 t. | 167 t. | 0 |
| 2023 | - | 176 t. | 226 t. | 314 t. | - |
| 2022 | - | 950 t. | 890 t. | 2.5 mio. | - |
| 2021 | - | 2 mio. | 1.6 mio. | 1.6 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout TLACPH Consulting ApS
TLACPH Consulting ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named TLACPH Consulting IVS and Norse Therapeutics IVS. The management consists of Thomas Lars Andresen. The company is owned by TLA-HOLDING 2010 ApS. According to the 2024 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 35,979 and a net result of DKK 34,074 compared with DKK 53,389 the year before. Equity in the 2025 report amounted to DKK 151,566.